The Olisa Foundation was founded by Dr. Nzedegwu R. Olisa, III. PhD as a multinational Texas corporate Trust in 2009. Foundation works to alleviate poverty and promote wellness through health security. To-this-end it trades as El-Paso Sub-Saharan Africa Union™ (ESAU) chamber of commerce; American Journal of Biological Defense® or AM J. BIO DEFN and International Molecular Diagnostic & Research Laboratories® or INTERLAB. Operationally, ESAU chamber of Commerce provides members brokerage and escrow services; AM J. BIO DEFN publishes Microbial Macroeconomics: Health Security Manual and Biological Agents Index (BAI) Laboratory Information System (LIS), while INTERLAB provides logistics for third-party infectious diseases testing laboratories in Africa and manufactures Olisferrol® (Braunmycin), an CXCR-antagonist antagonist taken once daily as antiinfection supplement with indication for community acquired opportunistic infections and some cancers linked with microbial etiology.